Exact Science

Quote from frenchfry:

Did somebody log the previous bars as well and is willing to share it?

The thing to do is post your annotated charts and I will correct them.

you need to make lists of the End Effects and for each one keep tabs on the gates and kills that either price formations or volume formations are creating.

In another thred a person posted a comment on the complexity of figuring out a complete system. He is correct for his way of thinking. BUT he is incorrect in terms of how thinking works and how neuroplasticity works. The mind can actually correct for wrong kinds of thinking.

As we see, there is no requirement for integrity in the financial industry or on the part of government regulators or their rule makers.

How the markets work is based upon human psychology which stems from neuroplasticity.

A good movie to watch which deals with a lot of levels of mental processes is Zero Dark Thirty.

Cell phone towers combined with mother love requirements sealed the deal.

trading is just a game that that has a set of elements (56). It is slightly more complex than was "Beat the Dealer" (52).

There are 11 volume names. There are 10 price names. There are 35 End Effects in 10 subsets.

In precise trading doing bar-by-bar analysis price gives permission (1) for a volume measure (2) to be taken. If so, then a test procedure is used (3) to determine continuaation in the primary (4) or the secondary (5). you have five monitoring and analysis interwoven processes (1 through 5)(6). 4 and 5 is one two level process. 6 is the process of processes interveaving.

A person starts with evidence and builds from a foundation.

Reading does not build the mind. There is a way growth occurs.

I mention BE DO HAVE every few years.

We all BE That is, we have minds. Cogito ergo sum.

DO This is a process where a goal is accomplished. You corectly reach the conclusion that there are no noise, no anomalies and no flaws. If you see any of these, make groups of categories for them. This is a place to focus. You eliminate these by repeatedly looking at the market.

HAVE To "get it" you BE and DO. Liz was outstanding salesperson again this year. She doesn't need another Rolex.
she wins because her clients give her so many referals. they reduce her sales territory each year.

All you have to do is go forward. I give you the carryover each day. you DO. As you notice, the market offers soooo much. As you see you compound. How much money is required?

HF's take a year to do the % you make in a part of a day. We just give money away as a consequence.

bar 78 can only be a P2 or a P3. If you have been in a trend for a few bars, what is bar 78 going to be? Can it be any easier to start every day on the correct side of the market?

Your mind will tell you where it hs questions? It tells you right at the moment. Journal your mind's curiousity.
 
Quote fromstonedinvestor

WHERE THE F AM I? WHY HAVE THE NY GIANTS NOT MADE THE PLAYOFFS? This thread it popped up in my mail... I had forgotten all about my friends... I feel bad. Hi Jack!

I have sold my position in Exact Sciences a long time ago. Thanks for bringing the name back to my attention.

Stool-based DNA (sDNA) technology and colorectal cancer screening never gets old. The results of the DeeP-C trial currently underway are expected to form the basis for submitting the non-invasive test for Pre-Market Approval with the FDA.

The DeeP-C study is a follow up to the company's recently presented results of a 1,003-patient case-control study that used the same technology as the DeeP-C trial. Among the study population, there were 93 cases of colorectal cancer, 114 cases of advanced pre-cancers and 796 controls. The Exact Sciences test detected 98% of colorectal cancers and 83% of pre-cancers with high-grade dysplasia, the majority of which progress to cancer.

The test demonstrated 57% sensitivity in the detection of advanced pre-cancers equal to or larger than 1 centimeter. The test's sensitivity increased with the size of the pre-cancers, rising to 83% for pre-cancers larger than 3 centimeters.

The company has three upcoming milestones in the approval process that should serve as catalysts for the stock.

In February, the company plans to submit the 2nd FDA module.

In March, Exact Sciences expects to announce topline results in the DeeP-C study.

In the April-May time period, the company plans to submit an application with the Centers for Medicare & Medicaid Services as well as submit the final FDA module containing clinical data.

Projections of Exact Sciences' annual revenue from this product top $500 million. The company now has virtually no revenues.

-Global opportunity is greater than $3 billion, with $1.2 billion of that being in the US.

-Roughly one-third of colorectal cancer-related deaths could be avoided with regular screening. Of those diagnosed, nearly half are expected to die within five years because most cases are detected when cancer has progressed and is less treatable. For those whose cancer is detected at an earlier stage, the five-year survival rate can be greater than 90%.

Personally Jack I don't like what I've heard about these regular tests for colon cancer. It sounds messy and impersonal and I won't do it. This product from EXACT SCIENCES could be a life saver for me.

Anyway I hope you are doing well and thanks for getting in touch. ~stoney
 
Back
Top